Tuesday, 23 Apr 2019

You are here

Mortality Predictors in Rheumatoid Arthritis

A population based study from southern Denmark finds excess mortality RF-positive males with rheumatoid arthritis (RA) and that employment status and comorbidity were independent predictors of mortality.

Investigators stuided 509 RA patients between 1995 to 2002, of whom 200 (39%) died during 6079 person-years of follow-up.

The most frequent underlying causes of death were cardiovascular disease (34%), neoplasms (26%), and respiratory disease (12%).

Seropositive (RF+) males hand an increased standardized mortality ratio of 1.47 (1.15-1.88), but also for cardiovascular disease 1.63 (1.09-2.46), respiratory disease 2.03 (1.06-3.90), and neoplasms 2.26 (1.02-5.03).  The SMR was great for those over age 79 years - SMR 2.45 (1.23-4.90).

RF modified the effect of age. Employment status, comorbidity, and gender were independent baseline predictors of subsequent mortality.

The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Statins in RA Patients Without CVD: Nonsignificant Results

Patients with RA, but without CV disease, who were treated with atorvastatin appeared to experience cardiovascular (CV) benefits similar to what has been observed in other populations, with a risk reduction of approximately one-third, according to a large, but prematurely terminated, trial in the U.K.

Increasing Prevalence and Consequences of Interstitial Lung Disease in RA

Interstitial lung disease (ILD) has been a hot topic in numerous journals recently with reports of increasing incidence and links to disease activity.

RheumNowLive On Demand: MTX Impact in RA - Dr. Michael Weinblatt

A clip from RheumNow Live On Demand. You can access the full library of content from the meeting.

RheumNowLive On Demand: Pre-Clinical RA - Dr. Michael Holers

A clip from RheumNow Live On Demand. You can access the full library of content from the meeting.

Artificial Intelligence to Predict Rheumatoid Disease Activity

A recent study in JAMA Network Open shows that artificial intelligence models can use electronic health record data to prognosticate future patient outcomes in rheumatoid arthritis (RA).